For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.
How you can devise a cancer prevention action plan.
How to love yourself — and your selfies — without filters or fillers.
Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations
Clinical Trial Title:
Step-Up yellow zone inhaled corticosteroids to prevent exacerbations
Clinical Trial Protocol ID:
14060501-IRB01
Clinical Trial Investigator Name:
James Moy, MD
Clinical Trial Protocol Description:
The objective of this study is to determine whether, in children receiving low-dose ICS, quintupling the dose of inhaled corticosteroids in the “yellow zone” based upon a symptom-based action plan reduces the rate of severe asthma exacerbations treated with oral corticosteroids.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have asthma.
- Be between the ages of 5-11 years old.
This is a partial list of inclusion criteria.
Clinical Trial Area:
Allergy and Asthma
Contact Phone:
(312) 563-4178
Contact Name:
Samantha Zitzer